🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests the combination of nivolumab and ipilimumab with ...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2024-07-24
Trial ID
NCT05896839
The research trial is testing the experimental drug pimasertib and the drug...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2011-05-27
Trial ID
NCT01378377
Treatments Being Tested
This phase I trial studies the side effects and best dose of ceritinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-06-22
Trial ID
NCT02321501
Treatments Being Tested
Objectives: Primary objective: Evaluate toxicity of rapamycin when used fo...
Status
Completed
Location
Primary Children's Medical Center
Start Date
2005-08
Trial ID
NCT00795886
Treatments Being Tested
Rationale: The Mammalian Target of Rapamycin (mTOR) is a large polypeptide...
Status
Completed
Location
Washington University School of Medicine
Start Date
2008-03
Trial ID
NCT00703170
Treatments Being Tested
In a previous randomized comparison oral sirolimus plus bare metal stent co...
Status
Completed
Location
Clinica IMA
Start Date
2006-01
Trial ID
NCT00552669
Treatments Being Tested
The main purpose of this study is to evaluate the safety and effectiveness ...
Status
Completed
Location
Urology Centers of Alabama, P.C.
Start Date
2015-04-29
Trial ID
NCT02407054
Treatments Being Tested
An open, single center, randomised study to investigate three different imm...
Status
Completed
Location
Clinic for transplantation immunology and nephrology
Start Date
2008-07
Trial ID
NCT01183247
Treatments Being Tested
The aim of this pilot phase trial is to assess the safety and tolerability,...
Status
Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2024-01-05
Trial ID
NCT06091332
Treatments Being Tested
This is a Phase 2 Study of Everolimus and Lenvatinib in patients with metas...
Status
Suspended
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2017-04-03
Trial ID
NCT03139747
Treatments Being Tested